Social networks
945 1,204 1,204Activities
Technologies
Entity types
Location
AMCO Building, 650 5th St, San Francisco, CA 94107, USA
San Francisco
United States of America
Employees
Scale: 11-50
Estimated: 13
Engaged corporates
2Added in Motherbase
5 years, 6 months agoLigandal is developing precision molecular therapeutics and targeted delivery technologies.
Ligandal is a genetic medicine company that uses nanotechnology to develop targeted and personalised therapies. As a regenerative medicine biotechnology company, Ligandal develops ultra-rapid therapeutics and vaccines for outbreaks and pandemics, in addition to its work in immuno-oncology and rare genetic diseases. Our current focus is on delivering a peptide-based cure to the COVID-19 pandemic (SARS-CoV-2 coronavirus), as part of a broader mission of enabling personalized medicine on a global scale through the power of nanomedicine and gene therapies.
Given that increasingly complex disease states require precise and custom-tailored medicine, much of our technology development has focused on combining gene therapy with targeting peptides to enable completely new paradigms in evolutionary medicine. Currently, we are utilizing a peptide nanoscaffold based approach for treating COVID-19 without a gene therapy component, with the goal of creating a combined antidote-vaccine. My expertise lies in targeted gene delivery, nano- and biomaterials, computational modeling of peptides, binding simulations, immunoengineering, as well as CRISPR and TALEN based gene editing. At Ligandal, we have demonstrated peptide-based delivery of CRISPR, RNA, DNA, siRNA, and a range of genes or proteins to virtually any cell type.
covid19, SARS-CoV-2 coronavirus, Coronavirus , immunoengineering, complex disease , and pharma
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Crunchbase Media, Software Development | Crunchbase Media, Software Development | Other 10 Feb 2018 | | |
Plug and Play Tech Center Startup accelerator & VC, Venture Capital and Private Equity Principals | Plug and Play Tech Center Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 8 Oct 2016 | |